<DOC>
	<DOCNO>NCT01755650</DOCNO>
	<brief_summary>The purpose study investigate safety potential effectiveness image compound 18F FPM find site malignancy .</brief_summary>
	<brief_title>Phase 0 18F FPM Using PET/CT Patients With Variety Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<criteria>Written inform consent obtain prior protocolspecific procedure Male female patient histologically confirm squamous cell carcinoma At least one site active malignancy , demonstrate prestudy 18F FDG PET/CT scan perform part routine clinical care Age &gt; /= 18 year Life expectancy &gt; /= 3 month ECOG Performance score 02 Pregnant breastfeeding female Systemic antineoplastic therapy within 2 week prior prestudy 18F FDG PET/CT scan 18F FPM PET/CT scan Any serious medical condition investigator feel may interfere procedure evaluation study Patients unwilling unable comply protocol history noncompliance inability grant inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>18F FPM</keyword>
	<keyword>PET/CT</keyword>
	<keyword>microdosing</keyword>
</DOC>